机译:Effectiveness and safety of ombitasvir, paritaprevir, ritonavir +/- dasabuvir +/- ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection
Hosp Univ Cruces, Bilbao, Spain;
Hosp Univ Puerta Mar, Cadiz, Spain;
Hosp Univ Virgen Rocio, Seville, SpainComplejo Hosp Albacete, Albacete, SpainHosp Univ Clin Valencia, INCLIVA, Valencia, SpainHosp Univ Donostia, Donostia San Sebastian, SpainHosp Univ La Princesa, Madrid, SpainCIBERehd, Madrid, SpainHosp Univ Puerta Hierro Majadahonda, IDIPHIM, Madrid, SpainIMIM Hosp Mar Med Res Inst, Hosp Mar, Barcelona, SpainHosp Univ A Coruna, La Coruna, SpainHosp Univ Marques Valdecilla, IDIVAL, Santander, SpainComplejo Hosp Univ Pontevedra, Pontevedra, SpainHosp Univ Vall DHebron, Barcelona, SpainHosp Univ Rio Hortega, Valladolid, SpainHosp Univ Miguel Servet, Zaragoza, SpainUniv Rey Juan Carlos, Hosp Univ Alcorcon, Madrid, SpainHosp Alvaro Cunqueiro, Vigo, SpainHosp Univ Cent Asturias, Oviedo, SpainHosp Univ Basurto, Bilbao, SpainHosp Univ Doce Octubre, Madrid, SpainHosp Univ Fdn Jimenez Diaz, Madrid, Spain;
compassionate use; dasabuvir; hepatitis C; ombitasvir; paritaprevir; severe fibrosis;